Live feed
Filing
SC 13G
SC 13G0001140361-18-033405·Artemis Investment Management LLP
Schedule 13G ownership disclosure
BIOXCEL THERAPEUTICS INC
Security class unavailable · CUSIP: 09075P105
Event date: 2018-07-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-18-033405
- Form type
- SC 13G
- Filer
- Artemis Investment Management LLP
- CIK
- CIK 1535385
- Filed
- Jul 25, 2018
- Reporting period
- Jul 24, 2018
- Description
- Schedule 13G beneficial ownership